Global Hospital-Acquired Infection Control Market to Reach $44.42 Billion by 2029, Growing at 5.5% CAGR

How Are the key drivers contributing to the expansion of the hospital-acquired infection control market?
The escalation of COVID-19 instances is predicted to fuel the expansion of the hospital-acquired infection control market in the future. COVID-19 is a viral infection brought on by the SARS-CoV-2 virus. The pandemic has escalated the demand for hospital-acquired infection control products and services, as they aim to enhance personal hygiene and boost the manufacturing of infection control medical supplies. The World Health Organization, a specialized agency of the United Nations based in Switzerland, reported that as of 8th August 2022, the global COVID-19 cases totaled 581.6 million. Thus, the rising number of COVID-19 cases is a significant factor propelling the growth of the hospital-acquired infection control market.

Get Your Hospital-Acquired Infection Control Market Report Here:
https://www.thebusinessresearchcompany.com/report/hospital-acquired-infection-control-global-market-report

What growth opportunities are expected to drive the hospital-acquired infection control market's CAGR through 2034?
In recent times, there's been a consistent growth in the hospital-acquired infection control market. Predictions suggest that the market size will increase from $34.59 billion in 2024 to $35.86 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 3.7%. The historic expansion of this market largely ties back to factors like rising antibiotic resistance, heightened awareness, strict regulations, global spread of infectious diseases, and initiatives undertaken for patient safety.

The market for controlling infections acquired in hospitals is predicted to experience significant expansion in the coming years. It is anticipated to rise to $44.42 billion in 2029, with a compound annual growth rate (CAGR) of 5.5%. The projected growth during this period can be attributed to factors such as the emergence of multidrug-resistant pathogens, preparation for pandemics, enhancement of surveillance and monitoring, antimicrobial stewardship programs, and international collaboration. Key trends expected to shape the market during the forecast period include the implementation of real-time location systems (RTLS), the incorporation of artificial intelligence (AI) in surveillance, a move towards single-use and disposable devices, focus on staff training and education, as well as an increase in the use of disinfection technologies.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7694&type=smp

What are the emerging trends shaping the future of the hospital-acquired infection control market?
Prominent firms in the hospital-acquired infection control market are striving to introduce cutting-edge technology solutions like AI systems, to enable early detection of sepsis for improved patient results through fast diagnosis and treatment. The AI system for early sepsis identification involves superior tech solutions that employ artificial intelligence and machine learning techniques for early recognition of sepsis symptoms in patients. For example, in April 2024, Prenosis Inc., a medical clinic based in the US, was granted marketing permission by the FDA for the Sepsis ImmunoScore, which is the first AI-powered system created to predict sepsis, a potentially fatal condition causing severe ramifications. This novel tool bolsters early identification via constant data analysis, empowering healthcare workers to act swiftly and efficiently. The incorporation of AI is designed to aid medical staff in decision-making, not to supplant them, ultimately enhancing patient results and cutting down healthcare expenses.

Which growth-oriented segments of the hospital-acquired infection control market are leading the industry's development?
The hospital-acquired infection control market covered in this report is segmented -

1) By Product: Sterilizers, Disinfectors, Endoscope Reprocessors, Microbial Testing Instruments, Consumables, Disinfectants, Infection Prevention And Surveillance Software, Other Products
2) By Technology: Phenotypic Methods, Genotypic Methods
3) By Diseases: Hospital Acquired Pneumonia, Bloodstream Infections, Surgical Site Infections, Gastrointestinal Infections, Urinary Tract Infection, Other Diseases
4) By Application: Disease Testing, Drug-Resistance Testing
5) By End User: Hospitals, ICUs, Ambulatory Surgical, Diagnostic Centers, Nursing Homes, Maternity Centers, Other End Users

Subsegments:
1) By Sterilizers: Steam Sterilizers, Ethylene Oxide Sterilizers, Hydrogen Peroxide Sterilizers
2) By Disinfectors: Washer Disinfectors, Automated Disinfectors
3) By Endoscope Reprocessors: High-Level Disinfection Reprocessors, Automated Endoscope Reprocessors
4) By Microbial Testing Instruments: Culture Systems, Rapid Microbial Testing Systems
5) By Consumables: Sterilization Wraps, Filters, Personal Protective Equipment (PPE)
6) By Disinfectants: Alcohol-based Disinfectants, Chlorine-based Disinfectants, Quaternary Ammonium Compounds
7) By Infection Prevention And Surveillance Software: Surveillance Software Solutions, Data Management Software
8) By Other Products: Cleaning Equipment, Air Purification Systems

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7694

What regions are leading the charge in the hospital-acquired infection control market?
North America was the largest region in the hospital-acquired infection control market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hospital-acquired infection control market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What companies are at the forefront of innovation in the hospital-acquired infection control market?
Major companies operating in the hospital-acquired infection control market include Johnson and Johnson, P&G Professional, Honeywell International Inc., MMM Group, 3M Company, Becton Dickinson and Company, Reckitt Benckiser Group plc., Ecolab Inc, Olympus Corporation, Miele Group, Biomerieux SA, Getinge AB, Halyard Health Inc., Ansell Limited, Sotera Health LLC, Contec Inc., Cantel Medical Corp., Belimed AG, Nanosonics Limited, Advanced Sterilization Products Services Inc, Steelco S.P.A, Schülke & Mayr GmbH, Metrex Research LLC, Tristel Solutions Ltd., Whiteley Corporation, PDI Inc., Steris Healthcare PVT Ltd, Matachana Group, Pal International Ltd., Xttrium Laboratories Inc., Zep Inc.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=7694&type=smp

What Is Covered In The Hospital-Acquired Infection Control Global Market Report?

•Market Size Forecast: Examine the hospital-acquired infection control market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the hospital-acquired infection control market for a structured understanding.
•Key Players Overview: Analyze major players in the hospital-acquired infection control market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the hospital-acquired infection control market.
•Segment Contributions: Evaluate how different segments drive overall growth in the hospital-acquired infection control market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the hospital-acquired infection control market.
•Industry Challenges: Identify potential risks and obstacles affecting the hospital-acquired infection control market.
•Competitive Landscape: Review strategic developments in the hospital-acquired infection control market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.